Mitchell Labiak

Mitchell Labiak is a business reporter known for covering significant developments in the financial and corporate sectors, particularly within the pharmaceutical industry. Recently, he reported on AstraZeneca's decision to pause its planned £200 million investment in a Cambridge research site, which was expected to create 1,000 jobs, highlighting the broader implications for the UK pharmaceutical market.